Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Big Pharma and Social Responsibility — The Access to Medicine Index
Home
Publications
Big Pharma and Social Responsibility — The Access to Medicine Index
Big Pharma and Social Responsibility — The Access to Medicine Index
Author:
HH
Hans V. Hogerzeil
Hans V. Hogerzeil
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
5 September 2013
journal article
Published by
Massachusetts Medical Society
in
New England Journal of Medicine
Vol. 369
(10)
,
896-899
DOI:
10.1056/nejmp1303723
PMID:
24004116
Abstract
The Access to Medicine Index, an independent initiative, ranks the world's 20 largest research-based pharmaceutical companies according to their efforts to make their products more available, affordable, and accessible in developing countries.
Keywords
MEDICINE INDEX
SOCIAL RESPONSIBILITY
BIG PHARMA
INDEPENDENT INITIATIVE
LARGEST RESEARCH-BASED
DEVELOPING COUNTRIES
RESEARCH-BASED PHARMACEUTICAL
PHARMACEUTICAL COMPANIES
ACCESS
MEDICINE
Related articles
Cited
Cited by 42 articles
Scroll to top